TROPION-Lung02: Datopotamab deruxtecan (Dato-DXd) plus pembrolizumab (pembro) with or without platinum chemotherapy (Pt-CT) in advanced non-small cell lung cancer (aNSCLC)-MedSci.cn

TROPION-Lung02: Datopotamab deruxtecan (Dato-DXd) plus pembrolizumab (pembro) with or without platinum chemotherapy (Pt-CT) in advanced non-small cell lung cancer (aNSCLC)

Goto, Y; Su, WC; Levy, BP; Rixe, O; Yang, TY; Tolcher, AW; Lou, YY; Zenke, Y; Savvides, P; Felip, E; Domine, M; Leventakos, K; Provencio, M; Horiike, A; Pan, E; Lin, D; Gu, J; Basak, P; Chisamore, MJ; Paz-Ares, LG

JOURNAL OF CLINICAL ONCOLOGY, 2023; 41 (16):

科室
- - 订阅+
  - 更多科室
工具
服务